Sign in

CIK 0001000694 · Large accelerated filer

NOVAVAX INC

Sign in to watch
Ticker
NVAX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
222816046
Phone
240-268-2000
Business address
21 FIRSTFIELD RD, GAITHERSBURG, MD
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. S-3/A Offering Registration Statement
  4. UPLOAD Other SEC-generated Letter
  5. UPLOAD Other SEC-generated Letter
  6. S-3 Offering Registration Statement
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. 4 Insider Changes in Ownership
  9. UPLOAD Other SEC-generated Letter
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 8-K Event Executive or director change
  16. 8-K Event Results of operations
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 10-Q Report Quarterly Report
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 38 of 83 · 1,649 filings